Smad1, Smad2, and Smad5 expressions decreased significantly during the mature phase after OM exposure compared to the control, while Smad2 and Smad5 expressions also decreased significantly during the mid-term and early phases, respectively. The gene discussed is SMAD2; the disease is ocular melanoma.